Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6051610A · kind A · utility
5Cited by
12References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 1999 |
| Grant date | Apr 18, 2000 |
| Priority date | — |
| Expiry date | Feb 18, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method and compositions for treating a patient having a neurological disease or disorder, such as stroke, head trauma, spinal cord injury, epilepsy, anxiety, or neurodegenerative diseases such as Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, or amyotrophic lateral sclerosis (ALS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.